QURE Prices Follow-On Offering At $29.50/Share

(RTTNews) - uniQure N.V. (QURE) has priced its follow-on public offering of 3 million ordinary shares at $29.50 each. The net proceeds of the follow-on public offering, which is scheduled to close on or about April 15, 2015, are expected to be approximately $82.4 million (EURO76.5 million).

The underwriters have a 30-day option to purchase up to an additional 450,000 ordinary shares from uniQure at the public offering price, less underwriting discounts.

uniQure went public on the NASDAQ Global Market on February 5, 2014, offering its shares at a price of $17 each.

On April 6, uniQure inked a strategic collaboaration with Bristol-Myers Squibb (BMY) to develop gene therapies for cardiovascular diseases.

Under the terms of the agreement, Bristol-Myers Squibb will make an upfront payment of $50 million, an initial equity investment of $32 million for a 4.9% stake in uniQure and a $15 million payment for selection of three collaboration targets. The agreement also entitles Bristol-Myers-Squibb to acquire an additional 5.0% ownership in uniQure before the end of this year.

QURE closed Thursday's trading at $30.79, down 7.65%.